Evidence map›Paper›PMID 26194736›Full record

ArticleScientific reports2015

Escherichia coli of sequence type 3835 carrying bla NDM-1, bla CTX-M-15, bla CMY-42 and bla SHV-12.

Yu Feng, Ping Yang, Yi Xie, Xiaohui Wang, Alan McNally, Zhiyong Zong

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Genomic characterization of tigecycline-resistantFrontiers in microbiology · 2023
    Article
  4. Molecular Characterization ofMicrobiology spectrum · 2022
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Shedding of OXA-181 carbapenemase-producingEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2019
    Article
  11. Article
  12. Article
  13. Plasmid-Mediated NovelAntimicrobial agents and chemotherapy · 2017
    Article
  14. Article
  15. The rapid spread of carbapenem-resistant Enterobacteriaceae.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 2016
    Review
  16. Article
  17. First Report of Complete Sequence of aFrontiers in cellular and infection microbiology · 2016
    Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yu Feng1] Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China [2] Division of Infectious Diseases, State Key Laboratory of Biotherapy, Chengdu, China.
Ping Yang1] Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China [2] Division of Infectious Diseases, State Key Laboratory of Biotherapy, Chengdu, China.
Yi XieLaboratory of Clinical Microbiology, Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Xiaohui Wang1] Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China [2] Division of Infectious Diseases, State Key Laboratory of Biotherapy, Chengdu, China.
Alan McNallyPathogen Research Group, Nottingham Trent University, Nottingham, UK.
Zhiyong Zong1] Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China [2] Division of Infectious Diseases, State Key Laboratory of Biotherapy, Chengdu, China [3] Department of Infection Control, West China Hospital, Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New Delhi metallo-β-lactamase (NDM) represents a serious challenge for treatment and public health. A carbapenem-resistant Escherichia coli clinical strain WCHEC13-8 was subjected to antimicrobial susceptibility tests, whole genome sequencing and conjugation experiments. It was resistant to imipenem (MIC, >256 μg/ml) and meropenem (MIC, 128 μg/ml) and belonged to ST3835. bla NDM-1 was the only carbapenemase gene detected. Strain WCHEC13-8 also had a plasmid-borne AmpC gene (bla CMY-42) and two extended-spectrum β-lactamase genes (bla CTX-M-15 and bla SHV-12). bla NDM-1 and bla SHV-12 were carried by a 54-kb IncX3 self-transmissible plasmid, which is identical to plasmid pNDM-HF727 from Enterobacter cloacae. bla CMY-42 was carried by a 64-kb IncI1 plasmid and bla CTX-M-15 was located on a 141-kb plasmid with multiple F replicons (replicon type: F36:A4:B1). bla CMY-42 was in a complicated context and the mobilisation of bla CMY-42 was due to the transposition of ISEcp1 by misidentifying its right-end boundary. Genetic context of bla NDM-1 in strain WCHEC13-8 was closely related to those on IncX3 plasmids in various Enterobacteriaceae species in China. In conclusion, a multidrug-resistant ST3835 E. coli clinical strain carrying bla NDM-1, bla CTX-M-15, bla CMY-42 and bla SHV-12 was identified. IncX3 plasmids may be making a significant contribution to the dissemination of bla NDM among Enterobacteriaceae in China.

Indexed as

beta-LactamasesEscherichia coliEscherichia coli ProteinsPhylogenyPlasmidsbeta-lactamase CMY-42, E colibeta-lactamase CTX-M-15beta-lactamase NDM-1beta-Lactamasesbeta-lactamase SHV-12Escherichia coli Proteins

Identifiers

PMID26194736
PMCPMC4508618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.